查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1969142

內視鏡治療設備市場：依產品類型、技術、應用、最終用戶和通路分類－2026-2032年全球預測

Endotherapy Devices Market by Product Type, Technology, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，內視鏡治療設備市場價值將達到 58 億美元，到 2026 年將成長至 62 億美元，到 2032 年將達到 99.2 億美元，複合年成長率為 7.96%。

主要市場統計數據
基準年 2025 58億美元
預計年份：2026年 62億美元
預測年份 2032 99.2億美元
複合年成長率 (%) 7.96%

內視鏡治療設備全面介紹：聚焦臨床發展、技術整合、安全重點與商業性促進因素，重塑其應用

在光學、材料科學和手術操作技術的整合發展推動下，內視鏡治療設備正迅速進入臨床和商業性化的成熟階段。臨床醫生日益需要能夠提供更佳視野、同時降低手術風險和縮短手術時間的工具，製造商也積極響應，推出了一系列創新產品，包括一次性平台、增強型成像模式和模組化服務交付模式。因此，採購團隊和臨床負責人正在重新評估關於設備生命週期、整體擁有成本和感染控制等方面的傳統觀念。

對推動內視鏡治療未來發展的變革性轉變進行分析：一次性產品的普及、影像技術的進步、人工智慧的應用以及監管轉折點。

內視鏡治療設備的格局正在經歷一場根本性的變革，遠不止於產品本身的改進。一次性、柔軟性及剛性內視鏡設備正在革新採購和感染控制模式，減輕再處理負擔，並改變服務經濟模式。同時，高清成像和窄頻成像等成像技術的創新提高了病灶檢測和治療的臨床標準，促使臨床醫生更傾向於選擇整合先進光學元件和改進照明的設備。

評估美國在 2025 年實施的關稅措施對供應鏈、採購決策和產品設計獎勵的累積影響。

2025年實施的關稅措施的累積影響已對整個內視鏡治療設備生態系統產生了即時和間接的影響。短期來看，進口關稅的提高推高了設備及其關鍵零件的到岸成本，迫使採購團隊重新評估其供應商組合併探索替代籌資策略。隨著相關人員將供應鏈韌性和可預測的前置作業時間置於優先地位，這種壓力正在加速對本地生產和近岸外包的興趣。

深入了解策略性細分，解釋產品、應用、最終用戶、通路和成像技術的差異如何影響臨床重點和商業化策略。

市場細分洞察揭示了產品、應用、終端用戶、分銷管道和技術方面的差異如何影響策略重點和創新路徑。以產品類型為基礎的市場結構包括軟式內視鏡內視鏡、硬式內視鏡內視鏡和膠囊內視鏡。軟式內視鏡進一步分為可重複使用軟式內視鏡和一次性軟式內視鏡，而硬式內視鏡則分為可重複使用硬式內視鏡和一次性硬式內視鏡。這種產品層面的細分會影響消毒通訊協定、設備人體工學設計和服務模式的決策，也是企業決定投資一次性器械還是耐用器械的重要因素。

各區域的關鍵見解：美洲、歐洲、中東和非洲以及亞太地區對採用趨勢、監管應對措施和製造策略的影響。

在全球內視鏡治療領域，區域趨勢持續影響技術應用模式、監管合作和生產策略。在美洲，完善的採購流程和對感染控制的高度重視推動了對一次性醫療器材和先進影像工具的需求。同時，區域創新中心正在支持臨床試驗和上市後證據的收集。健保報銷機制和醫院整合趨勢正在影響新技術快速融入手術流程，而大規模醫療系統作為早期採用者已證實可改善治療效果的技術的機構，發揮關鍵作用。

主要企業層級深入了解現有企業和新參與企業如何利用產品組合擴張、夥伴關係和證據產生來確保臨床准入和商業性優勢。

創新、服務經濟和策略聯盟的互動正在重塑主要企業之間的競爭動態。成熟的醫療設備製造商正在其產品組合中增加一次性產品、先進的成像功能和全面的服務契約，以加強與醫院的關係並創造可預測的收入來源。同時，專注於一次性產品、光學技術和數位分析的新興參與企業正利用密集的研發投入和靈活的商業化策略，爭取在特定應用場景和臨床環境中獲得支援。

為行業領導者提供切實可行的建議，以增強韌性、加快臨床部署，並使產品和商業策略與不斷變化的醫療保健提供者的優先事項保持一致。

產業領導者應採取一系列協作行動，以平衡短期韌性和長期競爭力。首先，應實現生產和採購多元化，以降低關稅風險和供應波動，同時評估近岸外包和區域組裝方案，從而縮短前置作業時間。同時，應優先考慮減少對關稅敏感部件依賴的產品設計，並簡化消毒流程，以滿足日益成長的感染控制要求。

採用嚴謹的混合調查方法，結合臨床醫生和採購負責人的原始資訊、二手證據以及專家檢驗，得出可靠的研究結果。

本執行摘要的研究採用混合方法，整合了質性一手訪談、二手文獻和結構化檢驗，以得出可靠的結論。一級資訊來源包括透過諮詢臨床專家、採購經理和醫療設備工程師收集的關於可用性、再處理負擔和臨床證據要求等方面的實地觀點。二手分析則利用監管指導文件、臨床試驗註冊資訊和同行評審文獻來檢驗技術聲明並分析監管趨勢。

簡潔的結論強調了以證據為基礎的創新、供應鏈韌性和綜合商業策略對於實現長期成長的必要性。

總之，內視鏡治療設備的格局正受到臨床、技術和商業性因素的共同影響而重塑，這要求企業具備策略靈活性。影像技術和設備設計的進步提高了診斷準確性和治療能力，而一次性平台和不斷變化的滅菌要求正在改變採購和服務模式。貿易趨勢和關稅措施正在加速供應鏈多元化，並促使人們重新關注區域製造策略。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 內視鏡治療設備市場：依產品類型分類

  • 膠囊內視鏡
  • 軟式內視鏡
  • 硬式內視鏡

第9章 內視鏡治療設備市場：依技術分類

  • 3D成像
  • 高清成像
  • 窄頻成像

第10章 內視鏡治療設備市場：依應用領域分類

  • 關節鏡
  • 胃腸內視鏡檢查
    • 下消化道內視鏡檢查
    • 上消化道內視鏡檢查
  • 肺內視鏡檢查
  • 泌尿系統視鏡檢查
    • 膀胱鏡檢查
    • 輸尿管鏡檢查

第11章 內視鏡治療設備市場：依最終用戶分類

  • 門診手術中心
  • 診所
  • 醫院

第12章 內視鏡治療設備市場：依通路分類

  • 直接競標
  • 批發商

第13章 內視鏡治療設備市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 內視鏡治療設備市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 內視鏡治療設備市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國內視鏡治療設備市場

第17章：中國內視鏡治療器材市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Boston Scientific Corporation
  • CONMED Corporation
  • Cook Medical LLC
  • ERBE Elektromedizin GmbH
  • Fujifilm Holdings Corporation
  • Globus Medical, Inc.
  • Intuitive Surgical, Inc.
  • Johnson & Johnson
  • Karl Storz SE & Co. KG
  • Medtronic PLC
  • Olympus Corporation
  • Otsuka Holdings Co., Ltd.
  • Pentax Medical Company, Ltd.
  • Renishaw PLC
Product Code: MRR-1A1A064C0676

The Endotherapy Devices Market was valued at USD 5.80 billion in 2025 and is projected to grow to USD 6.20 billion in 2026, with a CAGR of 7.96%, reaching USD 9.92 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 5.80 billion
Estimated Year [2026] USD 6.20 billion
Forecast Year [2032] USD 9.92 billion
CAGR (%) 7.96%

Comprehensive introduction to endotherapy devices highlighting clinical evolution, technology convergence, safety priorities, and commercial drivers reshaping adoption

Endotherapy devices have entered a phase of rapid clinical and commercial maturation driven by convergent advances in optics, materials science, and procedural practice. Clinicians increasingly demand tools that deliver superior visualization while reducing procedural risk and throughput time, and manufacturers are responding with innovations spanning single-use platforms, enhanced imaging modalities, and modular service offerings. As a result, procurement teams and clinical leaders are reconsidering long-standing assumptions around device lifecycle, cost of ownership, and infection control.

Moreover, the clinical imperative to improve patient outcomes and procedural efficiency is aligning with broader systemic priorities, including supply chain reliability and regulatory scrutiny. This alignment has elevated device sterility, ease of reprocessing, and interoperability with digital systems as core selection criteria. Consequently, companies that can demonstrate robust clinical evidence, streamlined logistics, and predictable total cost profiles are increasingly favored by hospital systems and ambulatory centers.

Taken together, these forces have reshaped competitive dynamics and created new entry points for technology providers. Strategic clarity around clinical value propositions, evidence generation, and channel engagement will determine which firms convert innovation into widespread adoption and sustained commercial success.

Analysis of transformative shifts driving the endotherapy landscape including single-use adoption, imaging advances, AI enablement, and regulatory inflection points

The landscape of endotherapy devices is changing in fundamental ways that extend beyond incremental product upgrades. Single-use flexible and rigid devices are transforming procurement and infection control paradigms, reducing reprocessing burdens and shifting service economics. At the same time, imaging innovations such as high-definition and narrow band imaging have raised the clinical bar for lesion detection and therapeutic precision, prompting clinicians to prefer devices that integrate advanced optics and improved illumination.

Concurrently, digital enablement through image analytics and early-stage artificial intelligence is beginning to influence workflow optimization and diagnostic consistency. Robotics and enhanced endoscope maneuverability are expanding procedural capabilities, reducing operator fatigue and broadening the range of minimally invasive interventions. These technological shifts are complemented by operational adjustments: health systems are consolidating supplier relationships, emphasizing service contracts and bundled procurement, while regulatory agencies are tightening guidance around device reprocessing and environmental safety.

As a result, companies must pivot from product-centric roadmaps to solutions that combine clinical evidence, digital integration, and lifecycle services. Those that successfully align innovation investments with evolving provider needs, reimbursement realities, and regulatory expectations will secure advantaged positions in an increasingly outcomes-driven market.

Assessment of the cumulative impact of United States tariff measures introduced in 2025 on supply chains, procurement decisions, and product design incentives

The cumulative effects of tariff measures introduced in 2025 have created immediate and second-order consequences across the endotherapy device ecosystem. In the near term, increased import duties have raised landed costs for devices and key components, prompting procurement teams to re-evaluate supplier portfolios and consider alternative sourcing strategies. This pressure has accelerated interest in local manufacturing and nearshoring initiatives, as stakeholders prioritize supply chain resilience and predictable lead times.

Over time, these trade measures have influenced product-level decisions. Manufacturers with geographically diversified production footprints have been better positioned to absorb cost pressure and maintain contractual pricing stability, whereas firms reliant on single-region supply have had to either renegotiate commercial terms or pass increased costs downstream. For healthcare providers, the tariff environment has heightened scrutiny of total ownership costs, sterilization expenditures, and the comparative economics of reusable versus single-use devices.

Furthermore, tariffs have catalyzed strategic responses beyond pricing. Some companies have intensified partnerships with distributors and local assemblers to mitigate duties, while others have increased investment in product designs that rely less on tariff-exposed components. In parallel, procurement organizations have leveraged longer-term agreements and volume commitments to secure price certainty. Ultimately, the tariff-driven adjustments are accelerating structural shifts that were already underway: a move toward supply chain diversification, heightened emphasis on domestic capabilities, and a renewed focus on demonstrable clinical and economic value.

Strategic segmentation insights explaining how product, application, end user, channel, and imaging technology distinctions influence clinical priorities and commercialization strategies

Insight into segmentation reveals how product, application, end user, distribution, and technology distinctions shape strategic priorities and innovation pathways. Based on product type the landscape includes capsule endoscopes alongside both flexible endoscopes and rigid endoscopes, with flexible models further differentiated into reusable flexible endoscopes and single-use flexible endoscopes while rigid endoscopes are examined across reusable rigid endoscopes and single-use rigid endoscopes. This product-level granularity influences decisions around sterilization protocols, device ergonomics, and service models, and it determines which firms invest in disposability versus durable instrumentation.

Based on application the field spans arthroscopy, gastrointestinal endoscopy, pulmonary endoscopy, and urological endoscopy, with gastrointestinal procedures further divided into lower and upper gastrointestinal endoscopy and urological procedures separated into cystoscopy and ureteroscopy. Each application segment imposes distinct clinical requirements, imaging preferences, and accessory ecosystems, thereby guiding product feature priorities and clinical evidence needs. Based on end user healthcare delivery settings range from ambulatory surgical centers to clinics and hospitals, and these settings exhibit different purchasing cycles, sterilization resources, and procedural volumes that affect device selection and service expectations.

Based on distribution channel procurement occurs through direct tender arrangements as well as distributor wholesaler networks, and channel choice impacts commercial models, service delivery, and aftermarket support. Based on technology offerings encompass 3D imaging, high definition imaging, and narrow band imaging, and these technological pathways drive differentiation in lesion detection capability, therapeutic accuracy, and integration with image analytics. Understanding the interplay among these segmentation axes is essential for tailoring product portfolios, targeting clinical partnerships, and aligning commercialization strategies with end-user workflows.

Key regional insights into how the Americas, Europe Middle East & Africa, and Asia-Pacific each shape adoption dynamics, regulatory interactions, and manufacturing strategies

Regional dynamics continue to dictate adoption patterns, regulatory interactions, and manufacturing strategies across the global endotherapy environment. In the Americas procurement sophistication and a strong emphasis on infection control have propelled interest in single-use devices and advanced imaging tools, while regional innovation hubs support clinical trials and post-market evidence generation. Meanwhile, reimbursement frameworks and hospital consolidation trends influence how quickly new technologies can be integrated into procedural pathways, with large health systems serving as early adopters for technologies that demonstrably improve outcomes.

In Europe, Middle East & Africa regulatory harmonization efforts and diverse payer landscapes create a mosaic of adoption timelines and cost sensitivities. In several European markets, centralized procurement and robust reprocessing infrastructures continue to support reusable device models, yet infection control imperatives and lifecycle cost scrutiny are increasing demand for single-use alternatives in specific clinical settings. Emerging markets within this region present growth opportunities linked to expanding procedural access and investments in diagnostic capacity, though pricing and infrastructure constraints require tailored go-to-market approaches.

Across Asia-Pacific a combination of rapid procedural uptake, growing domestic manufacturing capabilities, and policy emphasis on healthcare modernization has encouraged both innovation and competitive pressure. Local manufacturers and global firms operating in the region must navigate a range of regulatory regimes, local content expectations, and clinical training needs. Taken together, geographic distinctions underscore the necessity of region-specific commercialization playbooks that account for regulatory nuance, procurement mechanics, and clinical adoption drivers.

Key company-level insights into how incumbents and new entrants use portfolio expansion, partnerships, and evidence generation to secure clinical adoption and commercial advantage

Competitive dynamics among leading companies are being redefined by the interplay of innovation, service economics, and strategic partnerships. Established device manufacturers are expanding their portfolios to include single-use options, enhanced imaging capabilities, and bundled service agreements to lock in hospital relationships and create predictable revenue streams. At the same time, new entrants specializing in disposables, optics, or digital analytics are leveraging focused R&D and nimble commercialization to capture niche use cases and clinical champions.

Collaboration between device makers and clinical research organizations is becoming more strategic, with joint programs designed to produce robust evidence that supports adoption in procedural specialties. Similarly, alliances with distributors and local service providers are essential for scaling after-sales support and reprocessing alternatives in regions where centralized sterilization remains prevalent. Mergers, acquisitions, and licensing deals are playing a role in consolidating technology stacks and accelerating time-to-market for advanced imaging and single-use platforms.

Ultimately, companies that align R&D investments with clear clinical use cases, invest in training and service delivery, and create flexible commercial models will be positioned to win. Strategic clarity around aftermarket services, consumable economics, and digital integration will determine which players sustain profitable growth and long-term provider partnerships.

Actionable recommendations for industry leaders to enhance resilience, accelerate clinical adoption, and align product and commercial strategies with evolving provider priorities

Industry leaders should pursue a coordinated set of actions that balance near-term resilience with long-term competitiveness. First, diversify manufacturing and sourcing to reduce tariff exposure and supply volatility while also evaluating nearshoring or regional assembly options that improve lead times. In parallel, prioritize product designs that reduce reliance on tariff-sensitive components and that simplify sterilization to meet heightened infection control expectations.

Second, accelerate development of single-use offerings alongside durable platforms and create clear clinical and economic narratives that help providers assess total ownership and safety trade-offs. Evidence generation must be proactive: invest in pragmatic clinical studies and real-world data initiatives that demonstrate improvements in procedural outcomes, throughput, and cost-efficiency. Third, strengthen channel and service models by forming deeper partnerships with distributors and health systems, offering bundled maintenance or consumable agreements that create predictable revenue and improve customer retention.

Finally, engage early with regulators and payers to clarify clinical benefit thresholds and reimbursement pathways, and embed digital capabilities such as enhanced imaging interoperability and analytics to differentiate products. By integrating these strategic moves, organizations can transform short-term challenges into durable competitive advantages and align innovation with provider and patient needs.

Rigorous mixed-methods research methodology combining primary clinician and procurement inputs with secondary evidence synthesis and expert validation for defensible insights

The research underpinning this executive summary employs a mixed-methods approach that integrates primary qualitative interviews, secondary literature synthesis, and structured triangulation to ensure robust conclusions. Primary inputs included consultations with clinical specialists, procurement leaders, and device engineers to capture frontline perspectives on usability, reprocessing burdens, and clinical evidence requirements. Secondary analysis drew on regulatory guidance documents, clinical trial registries, and peer-reviewed literature to validate technological claims and map regulatory trends.

Data triangulation was applied across multiple sources to reconcile differing perspectives and to highlight consensus themes, such as the growing importance of single-use platforms and advanced imaging. Expert panels were convened to test preliminary findings and to identify risk factors related to supply chain disruption, tariff exposure, and adoption barriers. Where applicable, device lifecycle and procurement process frameworks were used to standardize comparisons across product types and end-user settings.

Limitations of the methodology include variability in publicly available clinical evidence across device categories and the dynamic nature of trade and regulatory environments. To mitigate these constraints, the study emphasizes qualitative validation, cross-regional comparisons, and scenario-based implications rather than quantitative forecasts, thereby providing actionable and defensible insights for strategic decision-making.

Concise conclusion emphasizing the need for evidence-driven innovation, supply chain resilience, and integrated commercial strategies to realize long-term growth

In conclusion, the endotherapy device landscape is being reshaped by a confluence of clinical, technological, and commercial forces that demand strategic agility. Advances in imaging and device design are enhancing diagnostic precision and therapeutic capability, while single-use platforms and evolving sterilization imperatives are altering procurement and service models. Trade dynamics and tariff measures have accelerated supply chain diversification and prompted renewed attention to regional manufacturing strategies.

Providers and manufacturers alike must prioritize evidence generation, supply chain resilience, and differentiated service models to thrive in this environment. By aligning product development with demonstrable clinical value and by engaging proactively with payers and regulators, organizations can navigate current headwinds and capitalize on emerging opportunities. The path forward requires integrated strategies that combine technological innovation, commercial flexibility, and deep clinical partnership to ensure that devices deliver measurable improvements in patient care and operational performance.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Endotherapy Devices Market, by Product Type

  • 8.1. Capsule Endoscopes
  • 8.2. Flexible Endoscopes
  • 8.3. Rigid Endoscopes

9. Endotherapy Devices Market, by Technology

  • 9.1. 3D Imaging
  • 9.2. High Definition Imaging
  • 9.3. Narrow Band Imaging

10. Endotherapy Devices Market, by Application

  • 10.1. Arthroscopy
  • 10.2. Gastrointestinal Endoscopy
    • 10.2.1. Lower Gastrointestinal Endoscopy
    • 10.2.2. Upper Gastrointestinal Endoscopy
  • 10.3. Pulmonary Endoscopy
  • 10.4. Urological Endoscopy
    • 10.4.1. Cystoscopy
    • 10.4.2. Ureteroscopy

11. Endotherapy Devices Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Clinics
  • 11.3. Hospitals

12. Endotherapy Devices Market, by Distribution Channel

  • 12.1. Direct Tender
  • 12.2. Distributor Wholesaler

13. Endotherapy Devices Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Endotherapy Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Endotherapy Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Endotherapy Devices Market

17. China Endotherapy Devices Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Boston Scientific Corporation
  • 18.6. CONMED Corporation
  • 18.7. Cook Medical LLC
  • 18.8. ERBE Elektromedizin GmbH
  • 18.9. Fujifilm Holdings Corporation
  • 18.10. Globus Medical, Inc.
  • 18.11. Intuitive Surgical, Inc.
  • 18.12. Johnson & Johnson
  • 18.13. Karl Storz SE & Co. KG
  • 18.14. Medtronic PLC
  • 18.15. Olympus Corporation
  • 18.16. Otsuka Holdings Co., Ltd.
  • 18.17. Pentax Medical Company, Ltd.
  • 18.18. Renishaw PLC

LIST OF FIGURES

  • FIGURE 1. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ENDOTHERAPY DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ENDOTHERAPY DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES ENDOTHERAPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA ENDOTHERAPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY CAPSULE ENDOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY CAPSULE ENDOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY CAPSULE ENDOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY RIGID ENDOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY RIGID ENDOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY RIGID ENDOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY 3D IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY 3D IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY 3D IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY HIGH DEFINITION IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY HIGH DEFINITION IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY HIGH DEFINITION IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY NARROW BAND IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY NARROW BAND IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY NARROW BAND IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY ARTHROSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY ARTHROSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY ARTHROSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY LOWER GASTROINTESTINAL ENDOSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY LOWER GASTROINTESTINAL ENDOSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY LOWER GASTROINTESTINAL ENDOSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY UPPER GASTROINTESTINAL ENDOSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY UPPER GASTROINTESTINAL ENDOSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY UPPER GASTROINTESTINAL ENDOSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY PULMONARY ENDOSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY PULMONARY ENDOSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY PULMONARY ENDOSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY UROLOGICAL ENDOSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY UROLOGICAL ENDOSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY UROLOGICAL ENDOSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY UROLOGICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY CYSTOSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY CYSTOSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY CYSTOSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY URETEROSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY URETEROSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY URETEROSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY DIRECT TENDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY DIRECT TENDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY DIRECT TENDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY DISTRIBUTOR WHOLESALER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY DISTRIBUTOR WHOLESALER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY DISTRIBUTOR WHOLESALER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. AMERICAS ENDOTHERAPY DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS ENDOTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 69. AMERICAS ENDOTHERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS ENDOTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS ENDOTHERAPY DEVICES MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS ENDOTHERAPY DEVICES MARKET SIZE, BY UROLOGICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS ENDOTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS ENDOTHERAPY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA ENDOTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA ENDOTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 77. NORTH AMERICA ENDOTHERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA ENDOTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA ENDOTHERAPY DEVICES MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 80. NORTH AMERICA ENDOTHERAPY DEVICES MARKET SIZE, BY UROLOGICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA ENDOTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA ENDOTHERAPY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA ENDOTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. LATIN AMERICA ENDOTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. LATIN AMERICA ENDOTHERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA ENDOTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA ENDOTHERAPY DEVICES MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 88. LATIN AMERICA ENDOTHERAPY DEVICES MARKET SIZE, BY UROLOGICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA ENDOTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA ENDOTHERAPY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA ENDOTHERAPY DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE, MIDDLE EAST & AFRICA ENDOTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE, MIDDLE EAST & AFRICA ENDOTHERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA ENDOTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE, MIDDLE EAST & AFRICA ENDOTHERAPY DEVICES MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA ENDOTHERAPY DEVICES MARKET SIZE, BY UROLOGICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA ENDOTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA ENDOTHERAPY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE ENDOTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE ENDOTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE ENDOTHERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE ENDOTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE ENDOTHERAPY DEVICES MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE ENDOTHERAPY DEVICES MARKET SIZE, BY UROLOGICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE ENDOTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE ENDOTHERAPY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 107. MIDDLE EAST ENDOTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. MIDDLE EAST ENDOTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. MIDDLE EAST ENDOTHERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST ENDOTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 111. MIDDLE EAST ENDOTHERAPY DEVICES MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 112. MIDDLE EAST ENDOTHERAPY DEVICES MARKET SIZE, BY UROLOGICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST ENDOTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST ENDOTHERAPY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 115. AFRICA ENDOTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. AFRICA ENDOTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. AFRICA ENDOTHERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 118. AFRICA ENDOTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 119. AFRICA ENDOTHERAPY DEVICES MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 120. AFRICA ENDOTHERAPY DEVICES MARKET SIZE, BY UROLOGICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 121. AFRICA ENDOTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. AFRICA ENDOTHERAPY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC ENDOTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC ENDOTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC ENDOTHERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC ENDOTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC ENDOTHERAPY DEVICES MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC ENDOTHERAPY DEVICES MARKET SIZE, BY UROLOGICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC ENDOTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC ENDOTHERAPY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. ASEAN ENDOTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. ASEAN ENDOTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. ASEAN ENDOTHERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 135. ASEAN ENDOTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 136. ASEAN ENDOTHERAPY DEVICES MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 137. ASEAN ENDOTHERAPY DEVICES MARKET SIZE, BY UROLOGICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 138. ASEAN ENDOTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 139. ASEAN ENDOTHERAPY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 140. GCC ENDOTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. GCC ENDOTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. GCC ENDOTHERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 143. GCC ENDOTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 144. GCC ENDOTHERAPY DEVICES MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 145. GCC ENDOTHERAPY DEVICES MARKET SIZE, BY UROLOGICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 146. GCC ENDOTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 147. GCC ENDOTHERAPY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPEAN UNION ENDOTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPEAN UNION ENDOTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPEAN UNION ENDOTHERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPEAN UNION ENDOTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPEAN UNION ENDOTHERAPY DEVICES MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPEAN UNION ENDOTHERAPY DEVICES MARKET SIZE, BY UROLOGICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPEAN UNION ENDOTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPEAN UNION ENDOTHERAPY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 156. BRICS ENDOTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. BRICS ENDOTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. BRICS ENDOTHERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 159. BRICS ENDOTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 160. BRICS ENDOTHERAPY DEVICES MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 161. BRICS ENDOTHERAPY DEVICES MARKET SIZE, BY UROLOGICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 162. BRICS ENDOTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. BRICS ENDOTHERAPY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 164. G7 ENDOTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 165. G7 ENDOTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. G7 ENDOTHERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 167. G7 ENDOTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 168. G7 ENDOTHERAPY DEVICES MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 169. G7 ENDOTHERAPY DEVICES MARKET SIZE, BY UROLOGICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 170. G7 ENDOTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 171. G7 ENDOTHERAPY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 172. NATO ENDOTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 173. NATO ENDOTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. NATO ENDOTHERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 175. NATO ENDOTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 176. NATO ENDOTHERAPY DEVICES MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 177. NATO ENDOTHERAPY DEVICES MARKET SIZE, BY UROLOGICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 178. NATO ENDOTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. NATO ENDOTHERAPY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 180. GLOBAL ENDOTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. UNITED STATES ENDOTHERAPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 182. UNITED STATES ENDOTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. UNITED STATES ENDOTHERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 184. UNITED STATES ENDOTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 185. UNITED STATES ENDOTHERAPY DEVICES MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 186. UNITED STATES ENDOTHERAPY DEVICES MARKET SIZE, BY UROLOGICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 187. UNITED STATES ENDOTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. UNITED STATES ENDOTHERAPY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 189. CHINA ENDOTHERAPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 190. CHINA ENDOTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. CHINA ENDOTHERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 192. CHINA ENDOTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 193. CHINA ENDOTHERAPY DEVICES MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 194. CHINA ENDOTHERAPY DEVICES MARKET SIZE, BY UROLOGICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 195. CHINA ENDOTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 196. CHINA ENDOTHERAPY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)